Skip to main content

Table 3 Medication in 114 patients with type 2 diabetes mellitus.

From: Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases

Therapy

Diabetes

Hypertension

Lipid-lowering

patients n (%) 114 (100)

patients n (%) 88 (77.2)

patients n (%) 28 (24.6)

Medications

diet

114 (100)

  

sulfonylureas

29 (25.4)

  

metformin

44 (38.6)

  

glitazones

2 (1.8)

  

glinides

7 (6.1)

  

carboanhydrase inhibitors

2 (1.8)

  

insulin (alone/combined)

52 (45.6)

  

statins/fibric acid

  

28 (24.6)

ACE inhibitors

 

40 (35.1)

 

calcium-channel blockers

 

19 (16.7)

 

diuretic drugs

 

41 (36.0)

 

beta-blockers

 

32 (28.1)

 

others

 

3 (2.6)

 
  1. Since combined therapies are possible, percentages/numbers might exceed 100